Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer
Open Access
- 29 November 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (2) , 2444-2456
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Yue Li1, *, Maoni Guo2, *, Zhenkun Fu3, *, Peng Wang2, Yan Zhang2, Yue Gao2, Ming Yue2, Shangwei Ning2, Dianjun Li3 1Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, China 2College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China 3Department of Immunology, Harbin Medical University, Harbin, 150081, China *These authors contributed equally to this work Correspondence to: Dianjun Li, email: dianjunli@163.com Shangwei Ning, email: ningsw@ems.hrbmu.edu.cn Keywords: immunoglobulin superfamily, breast cancer, network module, topology feature, prognostic biomarker Received: July 18, 2016 Accepted: November 22, 2016 Published: November 29, 2016 ABSTRACT Breast cancer progression is associated with dysregulated expression of the immunoglobulin superfamily (IgSF) genes that are involved in cell-cell recognition, binding and adhesion. Despite widespread evidence that many IgSF genes could serve as effective biomarkers, this potential has not been realized because the studies have focused mostly on individual genes and not the entire network. To gain a global perspective of the IgSF-related biomarkers, we constructed an IgSF-directed neighbor network (IDNN) and an IgSF-directed driver network (IDDN) by integrating multiple levels of data, including IgSF genes, breast cancer driver genes, protein-protein interaction (PPI) networks and gene expression profiling data. Our study shows that IgSF genes in the PPI network have important topological features related to cancer. Most IgSF genes are either cancer driver genes themselves or associated with them. We also identified a 21-gene IgSF network module with enriched mutations that are associated with overall survival based on 450 breast cancer patient samples extracted from The Cancer Genome Atlas (TCGA) and multiple independent microarray validation datasets. These results highlight the potential of IgSF genes as novel diagnostic, prognostic and therapeutic targets for breast cancer.Keywords
This publication has 44 references indexed in Scilit:
- Fut3 role in breast invasive ductal carcinoma: Investigating its gene promoter and protein expressionExperimental and Molecular Pathology, 2015
- Clinicopathological features of invasive lobular carcinoma of the breast: A nationwide multicenter study in ChinaJournal of Cancer Research and Therapeutics, 2015
- The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinomaOncotarget, 2015
- MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?BMC Cancer, 2015
- Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cellsBMC Cancer, 2011
- Identification of high-quality cancer prognostic markers and metastasis network modulesNature Communications, 2010
- Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasionCancer Cell International, 2010
- Network‐based classification of breast cancer metastasisMolecular Systems Biology, 2007
- ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.2006
- Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro.2003